Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048009
Status:
COMPLETED
Last Update Posted:
2017-06-19
First Post:
2002-10-24
Brief Title:
Evaluation of Various Doses of Ro 27-2771 Test Drug in Asthmatic Patients Not Treated With Inhaled Corticosteroids
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the appropriate dose of Ro 27-2441 test drug to be used in future studies assess the efficacy and safety and the anti-inflammatory action of the test drug in the treatment of asthmatic patients who are not currently receiving chronic therapy with corticosteroids The research is being conducted at up to 80 clinical research sites in the US Mexico and Canada Study participants will have a number of visits to a research site over approximately a 4-month period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None